Paul’s PhD work in chemical engineering focused on ways to study, and control, the structure of inorganic nanoparticles. His work has expanded the understanding of how atoms move to form nanoparticles. These insights have enabled expanded capabilities for nanoparticle design and potential next-generation applications in myriad sectors from medicine to clean energy.
As a Schmidt Science Fellow, Paul is working in the labs of Professor David R. Liu at the Broad Institute of MIT & Harvard and Professor Robert S. Langer at MIT, where he will pivot to biological engineering. He aims to develop new methods to identify organic nanoparticles that can functionally delivery genome editing drugs in vivo.
Paul hopes this work will lead to establishing a scalable platform to develop safe, effective therapies for genetic disorders.